You are here: Home » News-CM » Companies » Results
Business Standard

Glaxosmithkline Pharma standalone net profit rises 6.54% in the March 2015 quarter

Capital Market 

Sales rise 2.27% to Rs 613.47 crore

Net profit of Glaxosmithkline Pharma rose 6.54% to Rs 102.85 crore in the quarter ended March 2015 as against Rs 96.54 crore during the previous quarter ended March 2014. Sales rose 2.27% to Rs 613.47 crore in the quarter ended March 2015 as against Rs 599.85 crore during the previous quarter ended March 2014.

For the full year,net profit declined 6.02% to Rs 471.65 crore in the year ended March 2015 as against Rs 501.88 crore during the previous year ended December 2013. Sales rose 29.09% to Rs 3253.41 crore in the year ended March 2015 as against Rs 2520.17 crore during the previous year ended December 2013.

ParticularsQuarter EndedYear EndedMar. 2015Mar. 2014% Var.Mar. 2015Dec. 2013% Var.Sales613.47599.85 2 3253.412520.17 29 OPM %20.5017.94 -19.2820.72 - PBDT166.25152.48 9 825.86723.05 14 PBT161.50148.23 9 800.51703.17 14 NP102.8596.54 7 471.65501.88 -6

Powered by Capital Market - Live News

First Published: Mon, May 18 2015. 16:07 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU